| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 8
| Issue : 3 | Page : 197-200 |
|
|
Multisystem inflammatory syndrome in children associated with 2019 novel coronavirus (SARS-CoV-2) infection
Raj Kumar Gupta, Gayatri Dhanger, Vishal Gupta, Manohar Lal Gupta, Alok Goyal
Department of Pediatric Medicine, SMS Medical College, Jaipur, Rajasthan, India
Correspondence Address:
Gayatri Dhanger
F-3 Gangwal Park, Doctor's Flat, JLN Marg, Jaipur, Rajasthan
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cjhr.cjhr_19_21
|
|
|
Background: MIS-C is a serious condition that appears to be linked to novel coronavirus disease 2019, which is increasingly being reported worldwide. Here we report 10 children diagnosed with MIS-C. Aims and Objective: To describe the clinical and laboratory findings along with treatment and outcome of hospitalized children with multisystem inflammatory syndrome in children (MIS-C) associated with 2019 novel corona virus at SPMCHI, Jaipur. Methods: This was an observational study of 10 children who presented with MIS-C during 10-week duration from 1 October to 20 December 2020. Results: The median age of study was7 years. 8 patients had antibody test positive, 1 antigen by RTPCR was positive and 1 patient was negative. 4(40%) required intensive care unit admission and inotropic support. All patients received steroids, 4 (40%) IVIg, out of 10, 8(80%) survived and 2 (20%) expired. Conclusion: Children with MIS-C present with varied clinical presentation. There was a low RT-PCR positivity with high SARS-CoV-2 antibodies positivity. High index of suspicion is required for this clinical emerging complication of corona in children.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
